Wayne Yetter

Current

Director - Non-Executive Chairman at Noven Pharmaceuticals

Past

CEO at Verispan LLC
Director at Matria Healthcare
Director at Maxim Pharmaceuticals

CEO at Odyssey Pharmaceuticals
Non-Executive Chairman of the Board/Director at TKT
Advisor at Alterity Partners
Chairman & CEO at Synavant
Chief Operating Officer at IMS Health
CEO (US) at Novartis
CEO at Novartis Pharmaceuticals Corp.
CEO at AstraMerck
VP Far East and Pacific, VP Marketing Operations and other positions Human Health at Merck & Co.
VP Marketing Planning - Corporate Human Health Marketing at Merck

see less...

10 more...

Education

Bryant University
Wilkes University

Connections

262 connections

Industry

Pharmaceuticals

Wayne Yetter’s Experience

Director - Non-Executive Chairman

Noven Pharmaceuticals

(Public Company; NOVN; Pharmaceuticals industry)

2001 — Present (8 years)

Chairman of the Board since January 2008; Director from 2001. Noven is a specialty pharmaceutical company with expertise in transdermal drug delivery. Operations include the successful Novogyne women's health joint venture with Novartis.
CEO

Verispan LLC

(Privately Held; Pharmaceuticals industry)

September 2005 — August 2008 (3 years)

Joint venture of McKesson Corporation and Quintiles Transnational providing healthcare information, market research and services to leading pharmaceutical and biotechnology companies and government (FDA). Verispan was a leader in de-identified loongitudinal patient data. The company was acquired by SDI Health.
Director

Matria Healthcare

(Public Company; Pharmaceuticals industry)

2004 — May 2008 (4 years)

Lead Director - Matria acquired by Inverness Medical Innovations May 2008.
Director

Maxim Pharmaceuticals

(Public Company; Pharmaceuticals industry)

2004 — 2006 (2 years)
CEO

Odyssey Pharmaceuticals

(Pharmaceuticals industry)

2004 — 2005 (1 year)
Non-Executive Chairman of the Board/Director

TKT

(Pharmaceuticals industry)

1999 — 2005 (6 years)
Advisor

Alterity Partners

(Pharmaceuticals industry)

2003 — 2004 (1 year)
Chairman & CEO

Synavant

(Pharmaceuticals industry)

2000 — 2003 (3 years)
Chief Operating Officer

IMS Health

(Public Company; Pharmaceuticals industry)

1999 — 2000 (1 year)
CEO (US)

Novartis

(Pharmaceuticals industry)

1997 — 1999 (2 years)
CEO

Novartis Pharmaceuticals Corp.

(Public Company; Pharmaceuticals industry)

January 1997 — August 1999 (2 years 8 months)
CEO

AstraMerck

(Pharmaceuticals industry)

1992 — 1997 (5 years)
VP Far East and Pacific, VP Marketing Operations and other positions Human Health

Merck & Co.

(Public Company; Pharmaceuticals industry)

1978 — 1991 (13 years)
VP Marketing Planning - Corporate Human Health Marketing

Merck

(Public Company; 10,001 or more employees; MRK; Pharmaceuticals industry)

1986 — 1989 (3 years)